TD Waterhouse Canada Inc. Invests $9.59 Million in eMagin Co. $EMAN

TD Waterhouse Canada Inc. purchased a new stake in shares of eMagin Co. (NYSEAMERICAN:EMANFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,633,493 shares of the semiconductor company’s stock, valued at approximately $9,591,000. TD Waterhouse Canada Inc. owned approximately 5.57% of eMagin at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of EMAN. Mufg Securities Canada LTD. purchased a new stake in eMagin during the 2nd quarter valued at about $896,000. Van ECK Associates Corp purchased a new position in eMagin in the second quarter worth about $6,894,000. Royal London Asset Management Ltd. bought a new position in shares of eMagin in the second quarter worth approximately $744,000. Finally, Hsbc Holdings PLC bought a new position in shares of eMagin in the second quarter worth approximately $326,000. Hedge funds and other institutional investors own 33.36% of the company’s stock.

eMagin Price Performance

Shares of EMAN opened at $2.07 on Friday. The company has a market capitalization of $172.20 million, a P/E ratio of -13.80 and a beta of 2.03. The company has a quick ratio of 1.16, a current ratio of 2.06 and a debt-to-equity ratio of 1.59. The firm has a 50 day moving average of $2.07 and a 200 day moving average of $2.07. eMagin Co. has a twelve month low of $0.69 and a twelve month high of $2.49.

About eMagin

(Free Report)

eMagin Corporation, headquartered in Hopewell Junction, New York, is a technology company specializing in the design, development and manufacture of high-resolution organic light-emitting diode (OLED) microdisplays. Since its founding in 1996, eMagin has focused on delivering advanced active-matrix OLED (AMOLED) microdisplay solutions for near-to-eye applications, including virtual reality (VR), augmented reality (AR), military and industrial head-mounted systems, as well as medical imaging devices.

The company’s core product portfolio features monochrome and full-color OLED microdisplays that offer high contrast ratios, wide color gamut and low power consumption in a compact form factor.

See Also

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.